Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1

被引:114
作者
Holter, E
Kotaja, N
Mäkela, S
Strauss, L
Kietz, S
Jänne, OA
Gustafsson, JÅ
Palvimo, JJ
Treuter, E [1 ]
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Karolinska Inst, Dept Med Nutr, S-14157 Huddinge, Sweden
[3] Univ Turku, Dept Anat, FIN-20520 Turku, Finland
[4] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland
[5] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland
[6] Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
关键词
D O I
10.1210/me.16.3.515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
DAX-1 (NROB1) is an atypical member of the nuclear receptor family that is predominantly expressed in mammalian reproductive tissues. While a receptor function of DAX-1 remains enigmatic, previous work has indicated that DAX-1 inhibits the activity of the orphan receptor steroidogenic factor 1 and the estrogen receptors (ERs), presumably via direct occupation of the coactivator-binding surface and subsequent recruitment of additional corepressors. In vivo evidence points at a particular role of DAX-1 for the development and maintenance of male reproductive functions. In this study, we have identified the androgen receptor (AR) NR3C4 as a novel target for DAX-1. We show that DAX-1 potently inhibits ligand-dependent transcriptional activation as well as the interaction between the N- and C-terminal activation domains of AR. We provide evidence for direct interactions of the two receptors that involve the N-terminal repeat domain of DAX-1 and the C-terminal ligand-binding and activation domain of AR. Moreover, DAX-1, known to shuttle between the cytoplasm and the nucleus, is capable of relocalizing AR in both cellular compartments, suggesting that intracellular tethering is associated with DAX-1 inhibition. These results implicate novel inhibitory mechanisms of DAX-1 action with particular relevance for the modulation of androgen-dependent gene transcription in the male reproductive system.
引用
收藏
页码:515 / 528
页数:14
相关论文
共 66 条
[1]   CREB-binding protein in androgen receptor-mediated signaling [J].
Aarnisalo, P ;
Palvimo, JJ ;
Jänne, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2122-2127
[2]   Fertility and infertility: Genetic contributions from the hypothalamic-pituitary-gonadal axis [J].
Achermann, JC ;
Jameson, JL .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :812-818
[3]   Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita [J].
Altincicek, B ;
Tenbaum, SP ;
Dressel, U ;
Thormeyer, D ;
Renkawitz, R ;
Baniahmad, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7662-7667
[4]   Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue [J].
Bae, DS ;
Schaefer, ML ;
Partan, BW ;
Muglia, L .
ENDOCRINOLOGY, 1996, 137 (09) :3921-3927
[5]   STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT [J].
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G .
CELL, 1995, 83 (06) :851-857
[6]   Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines [J].
Beilin, J ;
Ball, EMA ;
Favaloro, JM ;
Zajac, JD .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) :85-96
[7]  
Bevan CL, 1999, MOL CELL BIOL, V19, P8383
[8]   Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function [J].
Buchanan, G ;
Yang, MO ;
Harris, JM ;
Nahm, HS ;
Han, GZ ;
Moore, N ;
Bentel, JM ;
Matusik, RJ ;
Horsfall, DJ ;
Marshall, VR ;
Greenberg, NM ;
Tilley, WD .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (01) :46-56
[9]   Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1 [J].
Crawford, PA ;
Dorn, C ;
Sadovsky, Y ;
Milbrandt, J .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2949-2956
[10]   Androgen receptor - an update of mechanisms of action in prostate cancer [J].
Culig, Z ;
Hobisch, A ;
Bartsch, G ;
Klocker, H .
UROLOGICAL RESEARCH, 2000, 28 (04) :211-219